News for Catalyst Biosciences, Inc. (CBIO)

News for Catalyst Biosciences, Inc.
Date Headline
Nov 14, 2017 08:49 AM Catalyst Biosciences Inc (CBIO): Time For A Financial Health Check
Nov 13, 2017 09:25 AM Catalyst Biosciences, Inc. :CBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
Sep 26, 2017 08:00 AM Catalyst Biosciences Granted FDA Orphan Drug Designation for Subcutaneous Recombinant Human Factor IX Variant for Treatment of Hemophilia B
Sep 25, 2017 08:01 AM Catalyst Biosciences Announces Successful Completion of First Subcutaneous Dosing Cohort in Ongoing Hemophilia B Clinical Trial
Sep 22, 2017 08:01 AM Catalyst Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 11, 2017 08:01 AM Catalyst Biosciences Announces Issuance of Asia Patents Covering Factor IX Hemophilia Program
Sep 07, 2017 08:00 AM Today's Research Reports on Trending Tickers: Athersys and Catalyst Biosciences
Sep 06, 2017 08:01 AM Catalyst Biosciences Announces Positive Factor IX Clinical Data
Sep 05, 2017 08:23 PM ETFs with exposure to Catalyst Biosciences, Inc. : September 6, 2017
Aug 24, 2017 11:01 AM Catalyst Biosciences, Inc. :CBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017